Fariborz Kamal is President and COO of 4D Molecular Therapeutics, Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
4D Molecular Therapeutics, Inc.
13 Dec 23
4
4D Molecular Therapeutics, Inc.
14 Feb 23
4
4D Molecular Therapeutics, Inc.
27 Sep 22
4
4D Molecular Therapeutics, Inc.
6 Sep 22
4
4D Molecular Therapeutics Inc.
3 Feb 22
4
4D Molecular Therapeutics Inc.
10 Mar 21
4
4D Molecular Therapeutics Inc.
17 Dec 20
3
4D Molecular Therapeutics Inc.
10 Dec 20
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
11 Dec 23 | FDMT 4D Molecular Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 14.42 | 260,000 | 3.75 mm | 260,000 |